These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Results of ISIS-3 reported at ACC annual meeting. Can J Cardiol; 1991 Apr; 7(3):VI-VII. PubMed ID: 1904302 [No Abstract] [Full Text] [Related]
24. GUSTO (Global Utilization of Streptokinase and Tissue plasminogen activator in Occluded arteries): logic wins at last. Bassand JP Eur Heart J; 1994 Jan; 15(1):2-4. PubMed ID: 8174579 [No Abstract] [Full Text] [Related]
25. Coronary artery thrombolysis: comparison of approved agents. Porter RS; DiPalma JR Am Fam Physician; 1991 Aug; 44(2):591-8. PubMed ID: 1907085 [TBL] [Abstract][Full Text] [Related]
26. Thrombolytic therapy in acute myocardial infarction: an emergency department perspective. Walters BL Henry Ford Hosp Med J; 1991; 39(3-4):184-94. PubMed ID: 1687142 [No Abstract] [Full Text] [Related]
28. Thrombolytic therapy for acute myocardial infarction. Are inclusion criteria too stringent? Handlin LR; Vacek JL Postgrad Med; 1994 Mar; 95(4):77-82. PubMed ID: 8121861 [TBL] [Abstract][Full Text] [Related]
29. Thrombolysis: state of the art. Sleight P Eur Heart J; 1993 Nov; 14 Suppl G():41-7. PubMed ID: 8287868 [TBL] [Abstract][Full Text] [Related]
30. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Barbash GI; White HD; Modan M; Van de Werf F J Am Coll Cardiol; 1993 Sep; 22(3):707-13. PubMed ID: 8354802 [TBL] [Abstract][Full Text] [Related]
31. A comparison between intravenous streptokinase and tissue plasminogen activator with early intravenous heparin in acute myocardial infarction. Cherng WJ; Chiang CW; Kuo CT; Lee CP; Lee YS Am Heart J; 1992 Apr; 123(4 Pt 1):841-6. PubMed ID: 1549990 [TBL] [Abstract][Full Text] [Related]
33. The GUSTO trial: is the open-artery hypothesis proven? Stringer KA; Lindenfeld J Ann Pharmacother; 1994 Jan; 28(1):97-8. PubMed ID: 8123971 [No Abstract] [Full Text] [Related]
34. Comparison of results of intravenous infusion of anistreplase versus streptokinase in acute myocardial infarction. Vogt P; Monnier P; Schaller MD; Goy JJ; Beuret P; Essinger A; Bachmann F; Hauert J; Perret C; Sigwart U Am J Cardiol; 1993 Feb; 71(4):274-80. PubMed ID: 8427167 [TBL] [Abstract][Full Text] [Related]
35. [t-PA in thrombolytic therapy of acute myocardial infarct]. Rutsch W; Schmutzler H Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690 [TBL] [Abstract][Full Text] [Related]
36. What you should know about thrombolytic therapy for acute MI. Aragon D; Martin M Am J Nurs; 1993 Sep; 93(9):24-31; quiz 33. PubMed ID: 8213959 [No Abstract] [Full Text] [Related]
37. Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy. Mahaffey KW; Granger CB; Collins R; O'Connor CM; Ohman EM; Bleich SD; Col JJ; Califf RM Am J Cardiol; 1996 Mar; 77(8):551-6. PubMed ID: 8610601 [TBL] [Abstract][Full Text] [Related]
38. Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Menon V; Harrington RA; Hochman JS; Cannon CP; Goodman SD; Wilcox RG; Schünemann HJ; Ohman EM Chest; 2004 Sep; 126(3 Suppl):549S-575S. PubMed ID: 15383484 [TBL] [Abstract][Full Text] [Related]